Nobel goes to immune checkpoint-Innovative cancer treatment by immunotherapy

Sci China Life Sci. 2018 Nov;61(11):1445-1450. doi: 10.1007/s11427-018-9409-7. Epub 2018 Oct 29.

Authors

Jing Li¹, Chen Dong^{2

3}

Affiliations

¹ Institute for Immunology and School of Medicine, Tsinghua University, Beijing, 100084, China.
² Institute for Immunology and School of Medicine, Tsinghua University, Beijing, 100084, China. chendong@tsinghua.edu.cn.
³ Beijing Key Lab for Immunological Research on Chronic Diseases, Beijing, 100084, China. chendong@tsinghua.edu.cn.

PMID: 30377902
DOI: 10.1007/s11427-018-9409-7

No abstract available

Publication types

News

MeSH terms

Animals
Antibodies, Blocking / immunology
Antibodies, Blocking / therapeutic use*
CTLA-4 Antigen / antagonists & inhibitors
CTLA-4 Antigen / immunology
Cancer Vaccines / immunology
Cancer Vaccines / therapeutic use*
Drug Discovery / trends
Humans
Immunosuppressive Agents / immunology
Immunosuppressive Agents / therapeutic use*
Immunotherapy*
Neoplasms / immunology
Neoplasms / therapy*
Programmed Cell Death 1 Receptor / antagonists & inhibitors
Programmed Cell Death 1 Receptor / immunology

Substances

Antibodies, Blocking
CTLA-4 Antigen
Cancer Vaccines
Immunosuppressive Agents
Programmed Cell Death 1 Receptor